Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Hormonal Regulation of the Menstrual Cycle

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-savings from fracture prevention with zoledronate in randomised controlled trials.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Same author

Mental disorders and osteoporosis treatment in patients with hip fracture-a Danish population-based cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026

Same author

Osteoporosis in chronic kidney disease: diagnostic dilemmas and therapeutic controversies.

Expert review of endocrinology & metabolism·2026

Same author

Management of Postmenopausal Osteoporosis.

Endocrine reviews·2026

Same author

Zoledronic acid for chronic kidney disease-associated osteoporosis.

Archives of osteoporosis·2026

Same author

Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026

Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 14, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

Postmenopausal osteoporosis.

Richard Eastell¹, Terence W O'Neill², Lorenz C Hofbauer³

¹Academic Unit of Bone Metabolism, and Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK.

Nature Reviews. Disease Primers

|September 30, 2016

Summary

This summary is machine-generated.

Osteoporosis is a bone disorder causing low bone mass and deterioration, increasing fracture risk, especially in older women. Prevention includes lifestyle changes and medications targeting bone resorption or formation.

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Mar 14, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Area of Science:

Bone Biology and Metabolism
Geriatric Medicine
Public Health

Background:

Osteoporosis is a metabolic bone disorder defined by low bone mass and deteriorating bone tissue microarchitecture.
It leads to fragility fractures, particularly in the proximal femur, vertebrae, and distal radius, posing a significant public health challenge due to an aging population.
Postmenopausal osteoporosis, driven by estrogen deficiency, elevates bone turnover, disrupting the balance between bone formation and resorption, affecting both trabecular and cortical bone structure.

Approach:

Diagnosis relies on bone density measurements of the lumbar spine and proximal femur.
Preventive measures encompass lifestyle modifications like diet, exercise, and smoking cessation.
Fall prevention strategies are crucial for high-risk populations to mitigate fracture incidence.

Key Points:

Estrogen deficiency in postmenopausal women significantly increases bone turnover, leading to bone loss.
Osteoporotic changes include loss of connectivity in trabecular bone and thinning/porosity in cortical bone.
Current treatments include bisphosphonates and denosumab to slow bone resorption, and teriparatide to stimulate bone formation.

Conclusions:

Osteoporosis is a major health concern, particularly for women over 50, with fractures severely impacting quality of life.
Effective management involves early diagnosis, preventive strategies, and pharmacotherapy.
Ongoing research into the cellular mechanisms of osteoporosis is driving the development of novel therapeutic agents.